发明名称 |
MODIFIED PEPTIDE AS THERAPEUTIC MEDICINE |
摘要 |
PROBLEM TO BE SOLVED: To provide fusion of Fc domains with biologically active peptides and pharmaceutical agents and compositions using biologically active peptides. SOLUTION: Pharmacologically active compounds are prepared by a process comprising: (a) selecting at least one peptide that modulates the activity of a protein of interest; and (b) preparing a pharmacologic agent comprising an Fc domain covalently linked to at least one amino acid of the selected peptide. Linkage to the vehicle increases the half-life of the peptide, which otherwise would be quickly degraded in vivo. The preferred vehicle is an Fc domain. The peptide is preferably selected by phage display, E. coli display, RNA-peptide screening, or chemical-peptide screening. COPYRIGHT: (C)2007,JPO&INPIT
|
申请公布号 |
JP2007084555(A) |
申请公布日期 |
2007.04.05 |
申请号 |
JP20060288325 |
申请日期 |
2006.10.24 |
申请人 |
AMGEN |
发明人 |
FEIGE ULRICH;LIU CHUAN-FA;CHEETHAM JANET;BOONE THOMAS CHARLES |
分类号 |
C07K19/00;G01N33/50;A61K38/00;A61P3/04;A61P7/06;A61P19/02;A61P29/00;A61P31/04;A61P31/12;A61P31/18;A61P35/00;A61P35/02;A61P37/02;A61P43/00;C07K;C07K14/47;C07K14/505;C07K14/52;C07K14/525;C07K14/545;C07K16/00;C07K16/18;C12N;C12N1/21;C12N9/64;C12N15/09;C12N15/62;C12N15/70;C12P21/02;C12R1/19;G01N33/15;G01N33/566 |
主分类号 |
C07K19/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|